Literature DB >> 9266631

Immunopathology of hepatitis C.

K M Chang1, B Rehermann, F V Chisari.   

Abstract

Hepatitis C virus (HCV) infection becomes persistent in the majority of instances in the face of a humoral and cellular immune response, and persistent HCV infection is associated with chronic hepatitis. In particular, cytotoxic T lymphocytes (CTL), crucial in the eradication of virus-infected cells, have been observed in the liver and the peripheral blood of chronically infected patients, suggesting that CTL cannot completely eliminate the virus, and may contribute to chronic liver injury. In this review, the potential host and the viral factors involved in the pathogenesis of chronic HCV infection will be discussed with emphasis on the HLA-A2 restricted peripheral blood CTL response and its relationship to liver disease and viral load.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266631     DOI: 10.1007/BF00945025

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  75 in total

1.  Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.

Authors:  C E Stevens; P E Taylor; J Pindyck; Q L Choo; D W Bradley; G Kuo; M Houghton
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

2.  Structure of the 3' terminus of the hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  The significance of blood transfusion in non-A, non-B chronic liver disease in Japan.

Authors:  K Kiyosawa; Y Akahane; A Nagata; Y Koike; S Furuta
Journal:  Vox Sang       Date:  1982-07       Impact factor: 2.144

4.  Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

Authors:  B Rehermann; K M Chang; J G McHutchison; R Kokka; M Houghton; F V Chisari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

5.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome.

Authors:  N Hiramatsu; N Hayashi; Y Haruna; A Kasahara; H Fusamoto; C Mori; I Fuke; H Okayama; T Kamada
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

7.  Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus.

Authors:  M Imawari; M Nomura; T Kaieda; T Moriyama; K Oshimi; I Nakamura; T Gunji; S Ohnishi; T Ishikawa; H Nakagama
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

Authors:  G Ballardini; P Groff; P Pontisso; F Giostra; R Francesconi; M Lenzi; D Zauli; A Alberti; F B Bianchi
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody.

Authors:  C Barbatis; J Woods; J A Morton; K A Fleming; A McMichael; J O McGee
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

10.  Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.

Authors:  M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  17 in total

1.  The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.

Authors:  Priyanka Shukla; Kristina N Faulk; Suzanne U Emerson
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

2.  Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus.

Authors:  Martina Sester; Urban Sester; Barbara Gärtner; Boris Kubuschok; Matthias Girndt; Andreas Meyerhans; Hans Köhler
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Modeling T cell responses to antigenic challenge.

Authors:  Dominik Wodarz
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-01       Impact factor: 2.745

4.  Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein.

Authors:  A Bergqvist; C M Rice
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Authors:  K M Chang; B Rehermann; J G McHutchison; C Pasquinelli; S Southwood; A Sette; F V Chisari
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions.

Authors:  M Pernollet; E Jouvin-Marche; V Leroy; I Vigan; J-P Zarski; P N Marche
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

7.  Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection.

Authors:  A S Moura; R A Carmo; A L Teixeira; V H R Leite; M O C Rocha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-18       Impact factor: 3.267

8.  Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Authors:  D J Kittlesen; K A Chianese-Bullock; Z Q Yao; T J Braciale; Y S Hahn
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.